Geissoschizine methyl ether, an alkaloid from the uncaria hook, improves remyelination after cuprizone-induced demyelination in medial prefrontal cortex of adult mice

Neurochemical Research

Volumn 39, Issue 1, 2014, Pages 59-67

  Morita, Shoko ^a   Tatsumi, Kouko ^a   Makinodan, Manabu ^a   Okuda, Hiroaki ^a   Kishimoto, Toshifumi ^a   Wanaka, Akio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Myelin; Remyelination; Schizophrenia; Yokukansan (Yi gan san)

Indexed keywords

BROXURIDINE; CELL MARKER; CUPRIZONE; DIMETHYL ETHER; GEISSOSCHIZINE; GEISSOSCHIZINE METHYL ETHER; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; SCHIZOPHRENIA; STEM CELL; TREATMENT DURATION; UNCARIA;

MUS; UNCARIA;

ANIMALS; CUPRIZONE; DEMYELINATING DISEASES; INDOLES; MICE; MYELIN BASIC PROTEIN; PREFRONTAL CORTEX; REGENERATION;

EID: 84892674846     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1190-1     Document Type: Article

References (35)

1. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927 (Pubitemid 32267079)
2. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60:443-456 (Pubitemid 36539053)
3. Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD (2002) Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 27:1193-1200 (Pubitemid 35316115)
4. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269-275 (Pubitemid 38251458)
5. Buchanan RW, Vladar K, Barta PE, Pearlson GD (1998) Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 155:1049-1055 (Pubitemid 28357730)
6. Buchsbaum MS, Hazlett EA (1998) Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 24:343-364 (Pubitemid 28378221)
7. Makinodan M, Rosen KM, Ito S, Corfas G (2012) A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337:1357-1360
8. Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839-855
9. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173 (Pubitemid 34438882)
10. Bagnall AM, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S, Davies L, Torgerson D, Kleijnen J (2003) A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 7:1-193
11. Iizuka S, Kawakami Z, Imamura S, Yamaguchi T, Sekiguchi K, Kanno H, Ueki T, Kase Y, Ikarashi Y (2010) Electron-microscopic examination of effects of yokukansan, a traditional Japanese medicine, on degeneration of cerebral cells in thiamine-deficient rats. Neuropathology 30:524-536
12. Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H (2005) A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66:248-252 (Pubitemid 40314333)
13. Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J (2008) Yi-gan san for the treatment of borderline personality disorder: an open label study. Progress Neuropsychopharmacol Biol Psychiatry 32:150-154
14. Miyaoka T, Furuya M, Kristian L, Wake R, Kawakami K, Nagahama M, Kawano K, Ieda M, Tsuchie K, Horiguchi J (2008) Yi-Gan San for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Progress Neuropsychopharmacol Biol Psychiatry 32:761-764 (Pubitemid 351312377)
15. Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J (2008) Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuropharmacol 32:6-9
16. Ueda T, Ugawa S, Ishida Y, Shimada S (2011) Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. Eur J Pharmacol 671:79-86
17. 1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience 207:124-136
18. Franco-Pons N, Torrente M, Colomina MT, Vilella E (2007) Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett 169:205-213 (Pubitemid 46436370)
19. Xu H, Yang HJ, Clough RW, Browning RA, Zhang Y, Li XM (2009) Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. Behav Neurosci 123:418-429
20. Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118:723-736
21. Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Takeda T, Kiuchi K, Sadamatsu M, Wanaka A, Kishimoto T (2009) Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 33:978-985
22. Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116
23. Buffo A, Vosko MR, Ertürk D, Hamann GF, Jucker M, Rowitch D, Götz M (2005) Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci USA 102:18183-18188 (Pubitemid 41798522)
24. Morita S, Oohira A, Miyata S (2010) Activity-dependent remodeling of chondroitin sulfate proteoglycans extracellular matrix in the hypothalamo-neurohypophysial system. Neuroscience 166:1068-1082
25. Morita S, Ukai S, Miyata S (2013) VEGF-dependent continuous angiogenesis in the median eminence of adult mice. Eur J Neurosci 37:508-518
26. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Academic Press, San Diego
27. Keirstead HS, Blakemore WF (1999) The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol 468:183-197 (Pubitemid 32197931)
28. Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A (2009) Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem Int 54:192-198
29. Kotter MR, Li WW, Zhao C, Franklin RJ (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328-332 (Pubitemid 43089546)
30. Madsen TM, Yeh DD, Valentine GW, Duman RS (2005) Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacology 30:27-34 (Pubitemid 40024396)
31. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122 (Pubitemid 34116557)
32. Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38-49 (Pubitemid 29015988)
33. Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R, Yamaguchi K, Hanyu H, Kanaya K, Takao T, Okada M, Kudo S, Kotoku H, Iwakiri M, Kurita H, Miyamura T, Kawasaki Y, Omori K, Shiozaki K, Odawara T, Suzuki T, Yamada S, Nakamura Y, Toba K (2009) A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol 12:191-199
34. Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S (2009) Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 33:308-311
35. Shinno H, Utani E, Okazaki S, Kawamukai T, Yasuda H, Inagaki T, Inami Y, Horiguchi J (2007) Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Progress Neuropsychopharmacol Biol Psychiatry 31:1543-1545 (Pubitemid 47302569)